MicroPort Scientific Acquires Hemovent GmbH

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

BioStem Technologies Acquires BioTissue's Surgical and Wound Care Business

January 22, 2026

Medical Devices

BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.

Integration Health Acquires ECMO Advantage

September 18, 2025

Healthcare Services

Integration Health has acquired ECMO Advantage, combining two leading ECMO, perfusion, and transplant support providers to create a unified national platform. The combined organization will serve over 55 hospitals across 22 states, expanding specialized clinical staffing, program development, transport, and education services for ECMO and perfusion care.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

Astorg Mid‑Cap Acquires Majority Stake in hg medical

May 5, 2023

Medical Devices

Astorg Mid‑Cap, the German arm of pan‑European private equity firm Astorg, has signed an agreement to acquire a majority stake in hg medical from NORD Holding. The transaction — terms undisclosed — will support management succession (COO Craig Bluett to become CEO, founder Johannes Hagenmeyer to move to an advisory role) and fund organic growth, capacity expansion and external M&A to scale hg medical's orthopaedic implant contract‑manufacturing platform across extremities and spine.